Penile tissue

Penile tissue is a complex anatomical structure and organ system rather than a single molecular target or receptor. It is primarily composed of the corpora cavernosa and corpus spongiosum, which are specialized vascular tissues that undergo significant hemodynamic changes to facilitate erection (StatPearls, 2023). While the tissue itself is not a therapeutic target, it houses several key molecular targets, most notably phosphodiesterase type 5 (PDE5), alpha-adrenergic receptors, and various cholinergic receptors (NIH, 2023). Drugs like sildenafil and tadalafil act on these specific molecular targets within the penile tissue to treat erectile dysfunction by promoting smooth muscle relaxation and increased blood flow (PubMed, 2004). Pathological conditions associated with this tissue include erectile dysfunction, Peyronie's disease, and priapism, which often involve dysregulation of the nitric oxide-cGMP pathway. Consequently, penile tissue serves as the site of action for various urological medications, though the actual therapeutic targets are the enzymes and receptors located within its cellular matrix.

Other names

PenisCorpus cavernosumCorpus spongiosumMale external genitalia

Pharmacological agents do not target the tissue as a whole but interact with specific molecular components within it, such as inhibiting phosphodiesterase type 5 (PDE5) to increase cGMP-mediated smooth muscle relaxation or activating prostaglandin E1 receptors to stimulate adenylate cyclase (PubMed, 2004; StatPearls, 2023).